Nektar Therapeutics (NKTR)
NASDAQ: NKTR · IEX Real-Time Price · USD
1.335
-0.045 (-3.26%)
Apr 25, 2024, 11:58 AM EDT - Market open
Nektar Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 1994 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 90.12 | 92.06 | 101.91 | 152.92 | 114.62 | 1,193 | 307.71 | 165.44 | 230.78 | 200.71 | Upgrade
|
| Revenue Growth (YoY) | -2.10% | -9.67% | -33.36% | 33.41% | -90.40% | 287.81% | 86.00% | -28.32% | 14.99% | 34.77% | Upgrade
|
| Cost of Revenue | 33.77 | 21.64 | 24.9 | 19.48 | 21.37 | 24.41 | 30.55 | 30.22 | 34.1 | 28.53 | Upgrade
|
| Gross Profit | 56.35 | 70.42 | 77.01 | 133.44 | 93.24 | 1,169 | 277.16 | 135.22 | 196.68 | 172.17 | Upgrade
|
| Selling, General & Admin | 77.42 | 92.33 | 122.84 | 104.68 | 98.71 | 81.44 | 52.36 | 44.28 | 43.27 | 40.93 | Upgrade
|
| Research & Development | 114.16 | 218.32 | 400.27 | 408.68 | 434.57 | 399.54 | 268.46 | 203.8 | 182.79 | 147.73 | Upgrade
|
| Other Operating Expenses | 128.46 | 135.93 | 0 | 45.19 | 0 | 0 | 15.98 | 0 | 0 | 0 | Upgrade
|
| Operating Expenses | 320.04 | 446.59 | 523.11 | 558.55 | 533.28 | 480.98 | 336.81 | 248.08 | 226.05 | 188.66 | Upgrade
|
| Operating Income | -263.68 | -376.17 | -446.1 | -425.11 | -440.04 | 687.93 | -59.64 | -112.86 | -29.37 | -16.49 | Upgrade
|
| Interest Expense / Income | 25.33 | 28.91 | 47.31 | 37.12 | 46.35 | 42.78 | 40.95 | 42.18 | 38.9 | 38.76 | Upgrade
|
| Other Expense / Income | -12.76 | -40.09 | 29.86 | -18.28 | -46.34 | -37.57 | -4.52 | -2.39 | 12.4 | -0.81 | Upgrade
|
| Pretax Income | -276.26 | -364.98 | -523.28 | -443.95 | -440.05 | 682.73 | -96.08 | -152.65 | -80.67 | -54.43 | Upgrade
|
| Income Tax | -0.2 | 3.22 | 0.56 | 0.49 | 0.61 | 1.41 | 0.62 | 0.88 | 0.51 | -0.51 | Upgrade
|
| Net Income | -276.06 | -368.2 | -523.84 | -444.44 | -440.67 | 681.31 | -96.69 | -153.52 | -81.18 | -53.92 | Upgrade
|
| Shares Outstanding (Basic) | 190 | 187 | 183 | 179 | 175 | 170 | 156 | 140 | 132 | 127 | Upgrade
|
| Shares Outstanding (Diluted) | 190 | 187 | 183 | 179 | 175 | 180 | 156 | 140 | 132 | 127 | Upgrade
|
| Shares Change | 1.53% | 2.09% | 2.64% | 2.05% | -2.85% | 15.50% | 11.72% | 5.39% | 4.40% | 9.63% | Upgrade
|
| EPS (Basic) | -1.45 | -1.97 | -2.86 | -2.49 | -2.52 | 4.02 | -0.62 | -1.10 | -0.61 | -0.42 | Upgrade
|
| EPS (Diluted) | -1.45 | -1.97 | -2.86 | -2.49 | -2.52 | 3.78 | -0.62 | -1.10 | -0.61 | -0.42 | Upgrade
|
| Free Cash Flow | -192.23 | -296.49 | -427.65 | -320.55 | -354.97 | 706.61 | -90.09 | -123.42 | -84.28 | -151.98 | Upgrade
|
| Free Cash Flow Per Share | -1.01 | -1.58 | -2.33 | -1.79 | -2.03 | 4.17 | -0.58 | -0.88 | -0.64 | -1.20 | Upgrade
|
| Gross Margin | 62.53% | 76.50% | 75.57% | 87.26% | 81.35% | 97.95% | 90.07% | 81.74% | 85.22% | 85.78% | Upgrade
|
| Operating Margin | -292.59% | -408.63% | -437.76% | -278.00% | -383.92% | 57.65% | -19.38% | -68.22% | -12.73% | -8.21% | Upgrade
|
| Profit Margin | -306.31% | -399.98% | -514.03% | -290.65% | -384.47% | 57.09% | -31.42% | -92.80% | -35.17% | -26.86% | Upgrade
|
| Free Cash Flow Margin | -213.30% | -322.08% | -419.65% | -209.62% | -309.70% | 59.21% | -29.28% | -74.60% | -36.52% | -75.72% | Upgrade
|
| Effective Tax Rate | - | - | - | - | - | 0.21% | - | - | - | - | Upgrade
|
| EBITDA | -243.11 | -323.04 | -461.82 | -392.65 | -380.54 | 736.37 | -40.38 | -95.12 | -28.92 | -2.74 | Upgrade
|
| EBITDA Margin | -269.75% | -350.92% | -453.18% | -256.77% | -332.01% | 61.71% | -13.12% | -57.49% | -12.53% | -1.37% | Upgrade
|
| Depreciation & Amortization | 7.82 | 13.03 | 14.15 | 14.18 | 13.16 | 10.87 | 14.74 | 15.35 | 12.86 | 12.93 | Upgrade
|
| EBIT | -250.92 | -336.07 | -475.97 | -406.83 | -393.7 | 725.5 | -55.12 | -110.47 | -41.77 | -15.67 | Upgrade
|
| EBIT Margin | -278.42% | -365.08% | -467.06% | -266.05% | -343.49% | 60.80% | -17.91% | -66.77% | -18.10% | -7.81% | Upgrade
|